NO20003813L - FremgangsmÕter for Õ redusere eller forhindre smerte ved bruk av spicamycin eller derivater derav - Google Patents
FremgangsmÕter for Õ redusere eller forhindre smerte ved bruk av spicamycin eller derivater deravInfo
- Publication number
- NO20003813L NO20003813L NO20003813A NO20003813A NO20003813L NO 20003813 L NO20003813 L NO 20003813L NO 20003813 A NO20003813 A NO 20003813A NO 20003813 A NO20003813 A NO 20003813A NO 20003813 L NO20003813 L NO 20003813L
- Authority
- NO
- Norway
- Prior art keywords
- spicamycin
- procedures
- derivatives
- reducing
- preventing pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
Fremgangsmåter for å gi smertelindring, som innbefatter de trinn å identifisere et dyr som trenger smertelindring, og å administrere en mengde av en forbindelse med formel (II) som er tilstrekkelig til å gi smertelindring.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/013,711 US5905069A (en) | 1998-01-26 | 1998-01-26 | Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
PCT/US1999/001518 WO1999037310A1 (en) | 1998-01-26 | 1999-01-26 | Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003813D0 NO20003813D0 (no) | 2000-07-25 |
NO20003813L true NO20003813L (no) | 2000-07-25 |
Family
ID=21761335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003813A NO20003813L (no) | 1998-01-26 | 2000-07-25 | FremgangsmÕter for Õ redusere eller forhindre smerte ved bruk av spicamycin eller derivater derav |
Country Status (9)
Country | Link |
---|---|
US (1) | US5905069A (no) |
EP (1) | EP1051182A1 (no) |
JP (1) | JP4712968B2 (no) |
KR (1) | KR20010040413A (no) |
CN (1) | CN1146430C (no) |
AU (1) | AU758342B2 (no) |
CA (1) | CA2317577A1 (no) |
NO (1) | NO20003813L (no) |
WO (1) | WO1999037310A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1169060B1 (en) * | 1999-04-09 | 2005-08-31 | Euro-Celtique S.A. | Sodium channel blocker compositions and the use thereof |
ES2365473T3 (es) * | 2000-09-20 | 2011-10-06 | The General Hospital Corporation | Procedimientos para reducir o prevenir el dolor usando derivados de espicamicina. |
AU2002232471A1 (en) * | 2000-10-31 | 2002-05-15 | Nutrition 21, Inc. | Methods and compositions for the treatment of polycystic ovary syndrome with chromium complexes |
DK1423168T3 (da) * | 2001-09-03 | 2006-05-15 | Newron Pharm Spa | Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse |
EP1809271B9 (en) * | 2004-09-10 | 2010-09-22 | Newron Pharmaceuticals S.p.A. | Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
US7860552B2 (en) * | 2004-10-01 | 2010-12-28 | The Mclean Hospital Corporation | CNS assay for prediction of therapeutic efficacy for neuropathic pain and other functional illnesses |
CA2738630A1 (en) * | 2008-10-10 | 2010-04-15 | Dara Biosciences, Inc. | Methods for treating or preventing pain using spicamycin derivatives |
JP2015524482A (ja) * | 2012-08-09 | 2015-08-24 | ダラ・バイオサイエンシズ,インコーポレイテッド | スピカマイシン誘導体を含む組成物およびその使用方法 |
WO2015061481A1 (en) | 2013-10-23 | 2015-04-30 | Dara Biosciences, Inc. | Methods of treating liquid tumors using compositions comprising spicamycin derivatives |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015811A1 (en) * | 1989-06-16 | 1990-12-27 | Kirin Beer Kabushiki Kaisha | Spicamycin x and its use |
JP2783722B2 (ja) * | 1991-07-12 | 1998-08-06 | 麒麟麦酒株式会社 | スピカマイシン誘導体およびそれを含む抗腫瘍剤 |
-
1998
- 1998-01-26 US US09/013,711 patent/US5905069A/en not_active Expired - Lifetime
-
1999
- 1999-01-26 CN CNB998024309A patent/CN1146430C/zh not_active Expired - Fee Related
- 1999-01-26 EP EP99904251A patent/EP1051182A1/en not_active Withdrawn
- 1999-01-26 KR KR1020007008134A patent/KR20010040413A/ko not_active Application Discontinuation
- 1999-01-26 JP JP2000528292A patent/JP4712968B2/ja not_active Expired - Fee Related
- 1999-01-26 WO PCT/US1999/001518 patent/WO1999037310A1/en not_active Application Discontinuation
- 1999-01-26 CA CA002317577A patent/CA2317577A1/en not_active Abandoned
- 1999-01-26 AU AU24693/99A patent/AU758342B2/en not_active Ceased
-
2000
- 2000-07-25 NO NO20003813A patent/NO20003813L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1289250A (zh) | 2001-03-28 |
US5905069A (en) | 1999-05-18 |
EP1051182A1 (en) | 2000-11-15 |
JP2002501028A (ja) | 2002-01-15 |
AU2469399A (en) | 1999-08-09 |
CN1146430C (zh) | 2004-04-21 |
JP4712968B2 (ja) | 2011-06-29 |
WO1999037310A1 (en) | 1999-07-29 |
CA2317577A1 (en) | 1999-07-29 |
KR20010040413A (ko) | 2001-05-15 |
NO20003813D0 (no) | 2000-07-25 |
AU758342B2 (en) | 2003-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
TR200200205T2 (tr) | MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi | |
DK1303632T3 (da) | Galactomannan-oligosaccharid og fremgangsmåde til fremstilling samt anvendelse heraf | |
EP0781136A4 (en) | COMPOUNDS AND METHODS FOR TREATING CANCER | |
TR199800585T2 (xx) | COX-2 �nhibit�rleri Olarak (Metils�lfonil)Fenil-2-(5H)-Furanonlar. | |
TR200102499T2 (tr) | Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi | |
AU1718400A (en) | Method for treating pain | |
AU2085201A (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
DK1143955T3 (da) | En kombination af FBPase-inhibitorer og insulinsensibiliseringsmidler til behandling af diabetes | |
NO20003813L (no) | FremgangsmÕter for Õ redusere eller forhindre smerte ved bruk av spicamycin eller derivater derav | |
DK0842165T3 (da) | Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler | |
EP1254260A4 (en) | METHODS FOR DIAGNOSING AND TREATING A HEART DISEASE | |
IL143516A0 (en) | COMPOUNDS AND METHODS FOR MODULATING ACTIVATION OF NF-k-B | |
DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
NO20003758L (no) | Trekonserveringsmidler | |
NO20001758L (no) | FremgangsmÕter og blandinger for behandling av leddgikt | |
AU3439799A (en) | Immunization against and treatment for infection by (h.pylori) | |
AU2001291133A1 (en) | Methods of decreasing or preventing pain using spicamycin derivatives | |
PT1137438E (pt) | Preparado com espectro terapeutico melhorado, contendo inibidores da sintese de nucleotidos | |
ES2135535T3 (es) | Derivados tiazolotriazol y tiazolodiazol con actividad fungicida. | |
AU2001251508A1 (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
AU2003238232A1 (en) | Compositions and methods for preventing, treating and diagnosing diabetes | |
WO2002076400A3 (en) | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | |
NZ526394A (en) | Sodium channel modulators derived from 2-piperidylimidazoles | |
DE59308900D1 (de) | (-)-metrifonat enthaltendes arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |